Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Dec 01, 2023

BUY
$0.57 - $0.99 $59,849 - $103,950
105,000 New
105,000 $87,000
Q2 2023

Aug 14, 2023

BUY
$0.57 - $0.99 $45,599 - $79,200
80,000 Added 61.54%
210,000 $174,000
Q2 2022

Aug 12, 2022

BUY
$0.71 - $2.43 $14,200 - $48,600
20,000 Added 18.18%
130,000 $128,000
Q1 2022

May 13, 2022

BUY
$2.31 - $5.13 $254,100 - $564,300
110,000 New
110,000 $262,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Dimension Capital Management LLC Portfolio

Follow Dimension Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimension Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dimension Capital Management LLC with notifications on news.